carnitine has been researched along with Adult Fanconi Syndrome in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The renal tubular Fanconi syndrome of children with nephropathic cystinosis causes plasma and muscle carnitine depletion." | 7.68 | Muscle carnitine repletion by long-term carnitine supplementation in nephropathic cystinosis. ( Bernardini, IM; Charnas, LR; Dalakas, MC; Gahl, WA; Krasnewich, DM; Markello, TC, 1993) |
| "11 children with either cystinosis or Lowe's syndrome had a reduced content of plasma and muscle carnitine due to renal Fanconi syndrome." | 7.67 | Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome. ( Bernar, J; Bernardini, I; Dalakas, M; Gahl, WA; Harper, GS; Hoeg, JM; Hurko, O; Rizzo, WB, 1988) |
| "The renal tubular Fanconi syndrome of children with nephropathic cystinosis causes plasma and muscle carnitine depletion." | 3.68 | Muscle carnitine repletion by long-term carnitine supplementation in nephropathic cystinosis. ( Bernardini, IM; Charnas, LR; Dalakas, MC; Gahl, WA; Krasnewich, DM; Markello, TC, 1993) |
| "11 children with either cystinosis or Lowe's syndrome had a reduced content of plasma and muscle carnitine due to renal Fanconi syndrome." | 3.67 | Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome. ( Bernar, J; Bernardini, I; Dalakas, M; Gahl, WA; Harper, GS; Hoeg, JM; Hurko, O; Rizzo, WB, 1988) |
| "Plasma and urine free and acyl carnitine were measured in 19 children with nephropathic cystinosis and renal Fanconi syndrome." | 3.67 | Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. ( Bernar, J; Bernardini, I; Dalakas, M; Gahl, WA; Rizzo, WB, 1985) |
| "Eventually, tyrosinemia type I was diagnosed." | 1.31 | Carnitine-deficient myopathy as a presentation of tyrosinemia type I. ( Ballin, A; Katzir, Z; Korman, SH; Lerman-Sagie, T; Levine, A; Nissenkorn, A; Vardi, O, 2001) |
| "The carnitine concentration was diminished in blood and muscle tissue." | 1.27 | Mitochondrial myopathy with lactic acidaemia, Fanconi-De Toni-Debré syndrome and a disturbed succinate: cytochrome c oxidoreductase activity. ( Guggenbichler, JP; Ruitenbeek, W; Sengers, RC; Sperl, W; Stadhouders, AM; Trijbels, JM, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ono, H | 3 |
| Sayed-Ahmed, MM | 1 |
| Hafez, MM | 1 |
| Aldelemy, ML | 1 |
| Aleisa, AM | 1 |
| Al-Rejaie, SS | 1 |
| Al-Hosaini, KA | 1 |
| Al-Harbi, NO | 1 |
| Al-Harbi, MM | 1 |
| Al-Shabanah, OA | 1 |
| Bieber, LL | 1 |
| Emaus, R | 1 |
| Valkner, K | 1 |
| Farrell, S | 1 |
| Gahl, WA | 3 |
| Bernardini, IM | 1 |
| Dalakas, MC | 1 |
| Markello, TC | 1 |
| Krasnewich, DM | 1 |
| Charnas, LR | 1 |
| Zamora, S | 1 |
| Benador, N | 1 |
| Lacourt, G | 1 |
| Girardin, E | 1 |
| Nissenkorn, A | 1 |
| Korman, SH | 1 |
| Vardi, O | 1 |
| Levine, A | 1 |
| Katzir, Z | 1 |
| Ballin, A | 1 |
| Lerman-Sagie, T | 1 |
| Sperl, W | 1 |
| Ruitenbeek, W | 1 |
| Trijbels, JM | 1 |
| Sengers, RC | 1 |
| Stadhouders, AM | 1 |
| Guggenbichler, JP | 1 |
| Kitano, A | 1 |
| Nishiyama, S | 1 |
| Miike, T | 1 |
| Hattori, S | 1 |
| Ohtani, Y | 1 |
| Matsuda, I | 1 |
| Bernardini, I | 2 |
| Dalakas, M | 2 |
| Rizzo, WB | 2 |
| Harper, GS | 1 |
| Hoeg, JM | 1 |
| Hurko, O | 1 |
| Bernar, J | 2 |
| Steinmann, B | 1 |
| Bachmann, C | 1 |
| Colombo, JP | 1 |
| Gitzelmann, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diagnosis and Treatment of Patients With Inborn Errors of Metabolism or Other Genetic Disorders[NCT00369421] | 4,000 participants (Anticipated) | Observational | 1978-09-12 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 other studies available for carnitine and Adult Fanconi Syndrome
| Article | Year |
|---|---|
Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation.
Topics: Adult; Anticonvulsants; Carnitine; Disabled Persons; Epilepsy; Fanconi Syndrome; Female; Humans; Int | 2019 |
[Correlation between renal tubular dysfunction and serum carnitine deficiency in cases with valproate therapy].
Topics: Adult; Anticonvulsants; Carnitine; Child; Child, Preschool; Fanconi Syndrome; Female; Humans; Male; | 2009 |
Downregulation of oxidative and nitrosative apoptotic signaling by L-carnitine in Ifosfamide-induced Fanconi syndrome rat model.
Topics: Animals; Apoptosis; Blood Urea Nitrogen; Carnitine; Caspases; Catalase; Creatinine; Disease Models, | 2012 |
[A severe disabled case of incomplete Fanconi syndrome after discontinuation of carnitine supplementation during valproate sodium therapy].
Topics: Anticonvulsants; Carnitine; Child; Disabled Children; Fanconi Syndrome; Female; Humans; Valproic Aci | 2007 |
Possible functions of short-chain and medium-chain carnitine acyltransferases.
Topics: Acetyl Coenzyme A; Acyltransferases; Amino Acids; Animals; Carnitine; Carnitine Acyltransferases; Fa | 1982 |
Muscle carnitine repletion by long-term carnitine supplementation in nephropathic cystinosis.
Topics: Carnitine; Child; Child, Preschool; Cystinosis; Drug Administration Schedule; Fanconi Syndrome; Huma | 1993 |
Renal handling of carnitine in ill preterm and term neonates.
Topics: Carnitine; Creatinine; Fanconi Syndrome; Gestational Age; Glycosuria; Humans; Infant, Newborn; Infan | 1995 |
Carnitine-deficient myopathy as a presentation of tyrosinemia type I.
Topics: Carnitine; Child, Preschool; Diagnosis, Differential; Fanconi Syndrome; Humans; Male; Muscle Hypoton | 2001 |
Mitochondrial myopathy with lactic acidaemia, Fanconi-De Toni-Debré syndrome and a disturbed succinate: cytochrome c oxidoreductase activity.
Topics: Acidosis, Lactic; Carnitine; Fanconi Syndrome; Female; Humans; Infant, Newborn; Lactates; Lactic Aci | 1988 |
Mitochondrial cytopathy with lactic acidosis, carnitine deficiency and DeToni-Fanconi-Debré syndrome.
Topics: Acidosis, Lactic; Carnitine; Electron Transport Complex IV; Fanconi Syndrome; Female; Humans; Infant | 1986 |
Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome.
Topics: Administration, Oral; Biological Transport; Carnitine; Cells, Cultured; Child; Child, Preschool; Cho | 1988 |
The renal handling of carnitine in patients with selective tubulopathy and with Fanconi syndrome.
Topics: Carnitine; Fanconi Syndrome; Fasting; Humans; Kidney; Kidney Tubules, Proximal; Mathematics | 1987 |
Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome.
Topics: Carnitine; Child; Child, Preschool; Cystinosis; Fanconi Syndrome; Humans; Infant; Kidney; Muscles | 1985 |